AVXL

Anavex Life Sciences Corp

NASDAQ: AVXL · HEALTHCARE · BIOTECHNOLOGY

$2.62

-1.50% today

Updated 2026-09-11

Market cap

$242.87M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.14

Dividend yield

—

52W range

$2 – $10

Volume

0.9M

Market cap

$242.87M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.14

Dividend yield

—

52W range

$2 – $10

Volume

0.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target

$20.00

+663.36%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-13.54M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-47.98M	$-47.49M	$-43.00M	$-46.38M	$-3.19M
EPS	—	—	—	—	$-0.14
Free cash flow	$-24.24M	$-27.79M	$-30.81M	$-39.04M	$-13.54M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-01-06	MISSLING, CHRISTOPHER U	Buy	125,000	—
2026-01-06	BOENISCH, SANDRA	Buy	12,500	—
2025-10-02	MISSLING, CHRISTOPHER U	Buy	125,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AVXL	$242.87M	24	4.3	3.0	5.0	6.0	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	2.7	6.0	-88.93%	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-69.36%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-73.74%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	6.0	-16.10%	Buy

Smart narrative

Anavex Life Sciences Corp trades at $2.62. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Anavex Life Sciences Corp's stock price?

Anavex Life Sciences Corp (AVXL) trades at $2.62.

Is Anavex Life Sciences Corp overvalued?

Anavex Life Sciences Corp carries a Smart Value Score of 24/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Anavex Life Sciences Corp (AVXL)?

The 12-month analyst consensus target is $20.00, about 663.4% above the current $2.62. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-31.55%

Beta1.14

50D MA$2.87

200D MA$3.48

Shares out0.09B

Float0.09B

Short ratio—

Avg volume0.9M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

AVXL vs LLY →AVXL vs JNJ →AVXL vs ABBV →Stock screener →